Chemical Structure (Regadenoson 01)
Regadenoson Injection, Solution
Product Images NDC 0409-1401
View Photos of Packaging, Regulatory Labels, and Product Appearance
Product Visual Gallery
This gallery contains 4 technical images submitted to the FDA as part of the official labeling for Regadenoson (NDC 0409-1401). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.
As provided by Hospira, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.
Logo (Regadenoson 02)
Principal Display Panel (0.4 mg/5 mL Syringe Label)
This is a product description of Regadenoson Injection, an intravenous medication used for pharmacologic stress tests. It is available in a single dose containing 0.4mg/5mL and has an NDC code of 0409-1401-05. The medication is distributed by Hospia, Inc with a LOT number of #H#-#HH-AA and an expiry date of DMMMYYYY.*
Principal Display Panel (0.4 mg/5 mL Syringe Carton)
This appears to be a set of instructions for using a pre-filled syringe for Regadenoson Injection, which is intended for diagnostic purposes. The text includes information about preparing the syringe for use, including removing the luer cover, holding the plunger and pushing the barrel forward, and pulling the barrel down until the liquid is expelled. It also includes details about administering the injection intravenously and following it immediately with saline. There is information about the manufacturer and distributor of the product, as well as its lot number and expiration date.*
* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.
